AAVBM launched in 2015 with four Asia-Australia countries (Australia, Japan, People's Republic of China and Republic of Korea). The meeting aims to provide a forum to exchange ideas and results of cutting-edge research in vascular biology. AAVBM features the exciting scientific programs with renowned speakers in the field reflecting diverse research topics in vascular biology from basic to translational level. AAVBM HP: https://jvbmo.umin.jp/en/aavbm.html
Date | November 1-2, 2025 DAY1 13:00~18:30(JVBMO2025 9:00~13:00) DAY2 8:50~12:00(JVBMO2025 12:00~16:45) |
---|---|
Venue | Ogawa Hideoki Hall, Bldg. 7, Juntendo University(Hongo-Ochanomizu Campus) 2-2-5 Hongo, Bunkyo City, Tokyo 113-8421, Japan https://en.juntendo.ac.jp/access.html https://maps.app.goo.gl/KFMw5dkawcSEi52z8 |
Main Theme | Vascular Biology and Medicine Pioneering for the Next Generation |
President of the conference | MINAMINO Tohru, M.D., Ph.D.
Professor and Chairman Director Principle Investigator |
Registration will open on July 1.
Date:November 1-2, 2025
11/1(Sat.)DAY1 13:00~18:30(JVBMO2025 9:00~13:00)
11/2(Sun.)DAY2 8:50~12:00(JVBMO2025 12:00~16:45)
Participants of AAVBM are also welcome to join JVBMO 2025. While the presentation language may be Japanese depending on the speaker, but the slides will be in English.
AAVBM participant
- | Early Bird rate 【JPY】 ends 10 October 2025 |
Regular rate 【JPY】 from 11 October 2025 |
---|---|---|
Standard | ¥13,000 | ¥15,000 |
Undergraduate/Medical Student* | ¥3,000 | ¥5,000 |
Reception party | - | ¥3,000 |
*Undergraduate/Medical students are to email a valid student ID to jvbmo2025@zenith-j.co.jp
【Cancellation & Refund Policies】
We do not accept any refunds after registration. Please check your schedule, travel arrangements, and other necessary details before completing your registration.
No refunds will be made to participants should the Meeting be cancelled or adapted to hybrid or virtual event formats due to circumstances not within the Organizer’s control including but not limited to any acts of God, civil commotion, outbreak, threat of outbreak, or ongoing transmission of infectious or communicable diseases such as SARS, COVID-19, failure of any applicable government authority to issue required governmental permits, and any other similar event or condition making it in advisable, impracticable, illegal or impossible to hold the event.
July 1, 2025 (Tuesday) – July 31, 2025 (Thursday)
Poster Presentation
Please select the category that best fits your abstract from the list below. This will assist with session organization.
01 | Aging/ Anti-aging | 17 | NO and Oxidative Stress |
---|---|---|---|
02 | Angiogenesis/ Vascular development | 18 | Pulmonary hypertension |
03 | Atherosclerosis/ Arteriosclerosis | 19 | Signal transduction |
04 | Biomedical engineering | 20 | Stem cells/ Progenitor cells |
05 | Cell differentiation/ Proliferation | 21 | Stroke/ Neurovascular disease |
06 | Computational model | 22 | Thrombosis |
07 | Diabetes/ Diabetic vascular complication | 23 | Transcriptional regulation |
08 | Epigenetics/ non-coding RNA | 24 | Translational research |
09 | Heart failure | 25 | Tumor angiogenesis/ Cancer biology |
10 | Hypertension | 26 | Vascular function |
11 | Hypoxia | 27 | New Technologies |
12 | Inflammation / Innate immunity | 28 | Genetics/Transcription |
13 | Lipid mediator | 29 | Mechanotransduction |
14 | Lipid metabolism/ Lipoprotein | 30 | Single Cell RNA Sequence |
15 | Lymph angiogenesis | 31 | Others |
16 | Metabolic syndrome/ Obesity |
■ Language & Word Count Limitations
■ Important Submission Notes
■ Submission & Revision Process
■ Deadline Reminders
Personal information submitted through the abstract registration and event participation process will be used for registration, notifications, abstract compilation, and inquiries. Information such as your name, affiliation, and contact details will be shared with the contracted publisher for abstract book editing and distribution. If you wish to limit the disclosure of your personal information, please contact the Management Secretariat.
A COI is required for all presentations. This should be placed at the end for poster presentations. The COI disclosure does not require verbal explanation.
The final decision regarding acceptance and presentation time will be made by the organizers and sent to the registered email address. Notifications will also be posted on the event website.
To register, modify, or delete your abstract, please click the link below to create a My Page and proceed to the abstract registration page:
Abstract Registration / Modification / Deletion LinkNote: Link redirects to Gsystem provided by Sho-Yaku Co., Ltd.)